Home / Going-concern warnings / Dare Bioscience, Inc.
Filed 2026-05-14 路 Form 10-Q 路 Accession 0001401914-26-000026 nano
Price before filing: $2.84 (2026-05-13 close, split/dividend-adjusted)
Market cap at flag: $41.5M (2026-05-14) 路 Latest: $10.8M (2026-10-16)
| Window | DARE | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -30.3% | +1.7% | -32.0% | 2026-06-15 |
| 90 days | -49.3% | +4.3% | -53.6% | 2026-08-12 |
| 180 days | pending | pending | until 2026-11-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Based on the Company's current analysis of the conditions described above, there is substantial doubt about the Company's ability to continue as a going concern within the 12 month period from the issuance date of the accompanying condensed consolidated financial statements given that the timing and amount of potential revenue the Company may generate remain uncertain."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.